Novavax reports fourth quarter and year-end 2014 financial results
Novavax reported a net loss of $82.9 million, or $0.37 per share for the 2014 year end versus a net loss of $52.0 million, or $0.31 per share for 2013. Revenue for the full year 2014 increased 47% to $30.7 million, compared to $20.9 million in 2013. February 26, 2015